Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calfactant - Ony

X
Drug Profile

Calfactant - Ony

Alternative Names: Infasurf; Infasurf Aero

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ony
  • Developer AbbVie; Ony
  • Class Phospholipids; Pulmonary surfactants
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Neonatal respiratory distress syndrome; Adult respiratory distress syndrome
  • New Molecular Entity No

Highest Development Phases

  • Marketed Neonatal respiratory distress syndrome
  • No development reported Acute lung injury; Bronchitis
  • Discontinued Adult respiratory distress syndrome

Most Recent Events

  • 27 Jul 2023 ONY in collaboration with Avania plans a phase III (Aero-05) trial for Neonatal respiratory distress syndrome (In infants, In neonates) in the USA in October 2023 (NCT05960929)
  • 28 Feb 2022 No recent reports of development identified for phase-I development in Bronchitis(In infants, In neonates) in USA (Inhalation, Aerosol)
  • 09 Apr 2021 No development reported - Phase-III for Neonatal respiratory distress syndrome (In neonates) in USA (Inhalation)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top